Adam D. Levy

Chief Financial Officer

Chief Financial Officer at Acrivon Therapeutics, Inc., filing insider transactions on 2026-01-14.

Total Purchases

$15K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-01-14

Last: 2026-01-14

Companies

Acrivon Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-01-14	ACRV	Purchase	8,832	$1.70	$15K	21.0K	SEC ↗